JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Thomas Jefferson University
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
University of Chicago
Barbara Ann Karmanos Cancer Institute
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Rutgers, The State University of New Jersey
European Organisation for Research and Treatment of Cancer - EORTC
Fred Hutchinson Cancer Center